The effect of vitamin B6 and folate supplements on plasma homocysteine and serum lipids levels in patients on regular hemodialysis

International Urology and Nephrology

Volumn 33, Issue 3, 2001, Pages 559-562

  Ziakka, Stavroula ^a   Rammos, Georgios ^b   Kountouris, Stefanos ^b   Doulgerakis, Christos ^b   Karakasis, Philipos ^b   Kourvelou, Christina ^b   Papagalanis, Nikolas ^b  

^a Nephrology Department of “Korgialenio Benakio” Hospital ^*  (Greece)

^b Korgialenio Benakio HRC Hospital   (Greece)

Author keywords

Atherogenic index; Folic acid; Hemodialysis; Homocysteine; Lipids

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; LIPID; PYRIDOXINE; ANTILIPEMIC AGENT; CHOLESTEROL; CYANOCOBALAMIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD; BODY MASS; CHRONIC KIDNEY FAILURE; DRUG EFFECT; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RISK FACTOR; AMINO ACID BLOOD LEVEL; ATHEROGENIC DIET; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; DIET RESTRICTION; DOSE RESPONSE; HEMODIALYSIS; HYPERLIPIDEMIA; KIDNEY FAILURE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; AGED; BODY MASS INDEX; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE, CHRONIC; LIPIDS; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS; VITAMIN B 6;

EID: 0035545338     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1019559328424     Document Type: Article

References (26)

1. The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients
2. Preventive health care, 2000 update: Screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventic Health Care
3. Elevated fasting total plasma homocystein levels and cardiovascular disease outcomes in maintenance dialysis patients: A prospective study
4. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients
5. Atherosclerosis risk factors: The possible role of homocysteine
6. Oral administration of homocysteine leads to increased plasma triglycerides and homocysteic acid-additional mechanisms in homocysteine induced endothelial damage?
7. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways
8. Hyperhomocysteinaemia: A role in the accelerated atherogenesis of chronic renal failure?
9. Hyperhomocysteiemia and the prevalence of atherosclerotic vascular disease in patients with end stage renal disease
10. Homocysteine and lipid metabolism in atherogenesis: Effect of the homocysteine thiolactonyl derivatives, thioretinaco and thioretinamide
11. A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease
12. Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete
13. Thermolabile variant of 5, 10-methylenetetrahydrofolate reductase associated with low red-cell folates: Implications for folate intake recommendations
14. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end stage renal failure
15. Homocysteine stimulates the production and secretion of cholesterol in hepatic cells
16. Homocysteine content of plasma proteins in ischemic heart disease
17. Homocysteine content of lipoproteins in hypercholesterolemia
18. Homocysteine content of lipoproteins in hypercholesterolemia
19. Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, covalamin, riboflavin, and troxerutin in atherosclerosis
20. Homocysteine metabolism and the oxidative modification of proteins and lipids
21. Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the serum of patients with myocardial infarction
22. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
23. Effect of usual doses of folate supplementation on elevated plasma homocysteine in hemodialysis patients: No difference between 1 and 5 mg daily
24. Oral folate reduces plasma homocysteine levels in hemodialysis patients with cardiovascular disease
25. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: Results of the Vienna multicenter study
26. Influence of folic acid, pyridoxal phosphate and covalamin on plasma homocysteine levels and the susceptibility of low density lipoprotein to ex vivo oxidation